Top-Ten of the Second International Congress on Glaucoma Surgery
February 6th-7th, 2003, Luxor, Egypt
Tarek Shaarawy
Electron microscopical examination of rhesus monkey eyes that had
undergone viscocanalostomy shows multiple breaks in the inner wall of
Schlemm's canal and traces of remaining viscoelastic material close
to the operations site, as well as 180° from the surgical site, four
weeks postoperatively (Tamm et al.)
Compared to drugs, surgery has the potential to fulfil many features
of an ideal approach for treating IOP: can lower IOP to the low teens,
achieve long-term IOP reduction, minimize IOP fluctuation, low costs,
has minimal systemic side-effects except for ocular ones; but the use
of surgery as first line treatment for IOP is limited by the high incidence
of potential ocular complications. There is a serious need for improving
surgical procedures in order to reduce ocular complications related
to glaucoma surgery (Haefliger et al.).
A four-year analysis of a randomized controlled trial comparing
the results of deep sclerectomy without an implant to trabeculectomy,
concludes that, if goniopuncture after deep sclerectomy is not considered
a failure criterion, the success rate of the two procedures is comparable,
even if 15 mmHg was used as the cut off IOP level of success. Deep sclerectomy
was associated with lower perturbation of lens nuclear transparency
and with a lower incidence of 'need-for' cataract extraction (Gandolfi
et al.).
Mitomycin eye drops after trabeculectomy in rabbit eyes seems to
produce a similar effect as the subconjunctival injection of mitomycin
on fibroblasts and collagen fibers, with no toxic effects on the conjunctival
epithelium, as demonstrated by electron microscopy (Abolnasr et al.).
On the first postoperative day, IOP can be used as a prognostic
indicator in non-penetrating glaucoma surgery. Patients with IOP <=
5 mmHg are significantly less likely to require goniopuncture. Significant
improvement was found in those with an initial IOP <= 5 in terms of
time to failure.
A randomized control trial comparing deep sclerectomy with and without
mitomycin concluded that augmentation of deep sclerectomy with mitomycin
C appears to increase the probability of maintaining a lower IOP, with
no additional side-effects after one year of follow-up (Mielke et
al.). o Interesting preliminary results with intrastromal diathermal
keratostomy 11 months after treatment (range, 7-15 months): complete
success in all eyes (mean IOP: 11 mmHg; range: 6- 15 mmHg), avoiding
the iris incarceration commonly seen after subconjunctival sclerostomy
(Kessing et al.)
In juvenile rheumatoid arthritis (JRA), 10% of children develop
chronic anterior uveitis. The iof secondary glaucoma in these children
ranges from 14-27%. Molteno tube shunt surgery is the first choice of
treatment in children with endogenous uveitis secondary to JRA (Airaksinen
& Valimaki).
Electrosurgical goniectomy is able to remove a full thickness central
strip of the trabecular meshwork overlying Schlemm's canal with minimal
collateral thermal damage (Baerveldt et al.).
The Ex-PRESS implant is an efficient method for lowering IOP in
combined surgery and is not associated with significant complications;
the speed of the implantation (three minutes) makes combined surgery
possible in some difficult cases. Optimal positioning of the device
during surgery is mandatory in order to avoid conjunctival erosion (Schnyder
& Mermoud).